PortfoliosLab logoPortfoliosLab logo
HALO vs. HELO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HALO vs. HELO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Halozyme Therapeutics, Inc. (HALO) and JPMorgan Hedged Equity Laddered Overlay ETF (HELO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HALO achieves a -1.52% return, which is significantly lower than HELO's 2.52% return.


HALO

1D
-2.73%
1M
3.63%
YTD
-1.52%
6M
-0.39%
1Y
19.12%
3Y*
25.45%
5Y*
11.28%
10Y*
21.28%

HELO

1D
-0.07%
1M
0.73%
YTD
2.52%
6M
3.21%
1Y
11.65%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HALO vs. HELO - Yearly Performance Comparison


2026 (YTD)202520242023
HALO
Halozyme Therapeutics, Inc.
-1.52%40.77%29.36%-3.25%
HELO
JPMorgan Hedged Equity Laddered Overlay ETF
2.52%7.82%18.05%6.30%

Correlation

The correlation between HALO and HELO is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Oct 2, 2023

0.28

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HALO vs. HELO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HALO
HALO Risk / Return Rank: 5656
Overall Rank
HALO Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
HALO Sortino Ratio Rank: 5555
Sortino Ratio Rank
HALO Omega Ratio Rank: 5353
Omega Ratio Rank
HALO Calmar Ratio Rank: 5757
Calmar Ratio Rank
HALO Martin Ratio Rank: 5555
Martin Ratio Rank

HELO
HELO Risk / Return Rank: 5353
Overall Rank
HELO Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
HELO Sortino Ratio Rank: 5555
Sortino Ratio Rank
HELO Omega Ratio Rank: 6262
Omega Ratio Rank
HELO Calmar Ratio Rank: 4141
Calmar Ratio Rank
HELO Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HALO vs. HELO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and JPMorgan Hedged Equity Laddered Overlay ETF (HELO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HALOHELODifference

Sharpe ratio

Return per unit of total volatility

0.64

1.89

-1.24

Sortino ratio

Return per unit of downside risk

1.06

2.65

-1.59

Omega ratio

Gain probability vs. loss probability

1.13

1.38

-0.25

Calmar ratio

Return relative to maximum drawdown

0.75

2.05

-1.30

Martin ratio

Return relative to average drawdown

1.45

9.10

-7.65

HALO vs. HELO - Sharpe Ratio Comparison

The current HALO Sharpe Ratio is 0.64, which is lower than the HELO Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of HALO and HELO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HALOHELODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.64

1.89

-1.24

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

0.23

1.65

-1.42

Drawdowns

HALO vs. HELO - Drawdown Comparison

The maximum HALO drawdown since its inception was -74.26%, which is greater than HELO's maximum drawdown of -10.89%. Use the drawdown chart below to compare losses from any high point for HALO and HELO.


Loading charts...

Drawdown Indicators


HALOHELODifference

Max Drawdown

Largest peak-to-trough decline

-74.26%

-10.89%

-63.37%

Max Drawdown (1Y)

Largest decline over 1 year

-24.13%

-5.76%

-18.37%

Max Drawdown (3Y)

Largest decline over 3 years

-33.92%

Max Drawdown (5Y)

Largest decline over 5 years

-49.06%

Max Drawdown (10Y)

Largest decline over 10 years

-49.06%

Current Drawdown

Current decline from peak

-18.40%

-0.07%

-18.33%

Average Drawdown

Average peak-to-trough decline

-31.91%

-1.18%

-30.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.56%

1.30%

+11.26%

Volatility

HALO vs. HELO - Volatility Comparison

Halozyme Therapeutics, Inc. (HALO) has a higher volatility of 10.41% compared to JPMorgan Hedged Equity Laddered Overlay ETF (HELO) at 0.66%. This indicates that HALO's price experiences larger fluctuations and is considered to be riskier than HELO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HALOHELODifference

Volatility (1M)

Calculated over the trailing 1-month period

10.41%

0.66%

+9.75%

Volatility (6M)

Calculated over the trailing 6-month period

24.18%

5.00%

+19.18%

Volatility (1Y)

Calculated over the trailing 1-year period

29.89%

6.20%

+23.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.47%

7.96%

+31.51%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.89%

7.96%

+34.93%

Dividends

HALO vs. HELO - Dividend Comparison

HALO has not paid dividends to shareholders, while HELO's dividend yield for the trailing twelve months is around 0.62%.


PositionTTM202520242023
HALO
Halozyme Therapeutics, Inc.
0.00%0.00%0.00%0.00%
HELO
JPMorgan Hedged Equity Laddered Overlay ETF
0.62%0.67%0.60%0.19%

Frequently Asked Questions


HALO and HELO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HALO has higher volatility (10.41%) compared to HELO (0.66%). In terms of maximum drawdown, HALO dropped -74.26% vs HELO's -10.89%.

HELO currently has the higher Sharpe Ratio (1.89 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HALO and HELO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer